1. Home
  2. /
  3. Availability
  4. /
  5. Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries.

Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries.

Description

To aid in prioritizing the development of tuberculosis (TB) vaccines most likely to reach the 2050 TB elimination goal, we estimated the impact and cost-effectiveness of a range of vaccine profiles in low- and middle-income countries.

Resources

Contact

Joeri Buis

KNCV Team

Contact me for more information about this research

Click to copy link of this header Menu

Add A Knowledge Base Question !

You will receive an email when your question will be answered.

+ = Verify Human or Spambot ?